INTERNATIONAL PATENT: HANMI PHARM. CO., LTD., 한미약품 주식회사 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION COMPRISING EFPEGLENATIDE AS ACTIVE INGREDIENT AND ADMINISTRATION THERAPY THEREOF"

GENEVA, July 3 -- HANMI PHARM. CO., LTD. (214, Muha-ro, Paltan-myeon,Hwaseong-si,Gyeonggi-do 18536), 한미약품 주식회사 (경기도화성시팔탄면 무하로 214) filed a patent application (PCT/KR2024/097176) for "PHARMACEUTICAL COMPOSITION COMPRISING EFPEGLENATIDE AS ACTIVE INGREDIENT AND ADMINISTRATION THERAPY THEREOF" on Dec 19, 2024. With publication no. WO/2025/136071, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Invent...